Matthew Liddelow, Chief Executive Officer at Neuroscientific Biopharmaceuticals Ltd., holds 1.13M shares in Neuroscientific Biopharmaceuticals Ltd. (Ticker: AU:NSB). Most recently, Matthew Liddelow Bought AU$50,000 shares of Neuroscientific Biopharmaceuticals Ltd. on May 18, 2021 for an estimated value of 12.15K.
What is the percentage of profitable transactions made by Matthew Liddelow?
The percentage of profitable transactions made by Matthew Liddelow is ―.
What is the average return per transaction made by Matthew Liddelow?
The average return per transaction made by Matthew Liddelow is ―.
What stocks does Matthew Liddelow hold?
Matthew Liddelow holds: AU:NSB stocks.
What was Matthew Liddelow’s latest transaction?
Matthew Liddelow latest transaction was an Informative Buy of AU$12.15K.
What was Matthew Liddelow's most profitable transaction?
Matthew Liddelow’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Matthew Liddelow's role in Neuroscientific Biopharmaceuticals Ltd.?
Matthew Liddelow's role in Neuroscientific Biopharmaceuticals Ltd. is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.